The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...
Three major drug middlemenneedlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 billion ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback